Explore the rise of TOP1i-class payloads, the impact of payload–linker design on therapeutic window and developability, and how novel payloads are expanding ADC design boundaries.
Scientific Reviews
-
-
Review the evolution of molecular glues from serendipitous discovery to rational design, highlighting how emerging targets and advances in screening, proteomics, structural biology, and AI are expanding the druggable proteome. -
Explore the mechanisms driving immune tolerance breakdown in autoimmune diseases and emerging tolerance-restoring strategies, with a focus on IL-2-based immune modulation. -
Explore the evolution from GLP-1 mono-agonists to multi-receptor therapeutics and the expanding role of incretin-based therapies in precision metabolic medicine. -
Explore the limitations of conventional virtual screening, advances in AI-enabled molecular discovery, and their impact on early-stage drug discovery. -
.png)
Explore lessons from KRAS G12C inhibitors, advances from G12D to Pan-RAS targeting, and emerging strategies to overcome resistance and reshape the tumor microenvironment. -
Explore CRC molecular subtypes, immune landscapes, resistance mechanisms, and emerging precision strategies for improving outcomes across distinct subtypes. -
.png)
Explore AOC design principles, delivery challenges, and clinical advances that are expanding the reach of precision RNA medicine. -
Review the transition from Casgevy to next-generation base editing, focusing on technological advances, delivery challenges, and the future of programmable medicine. -
Explore MS-based proteomics through sample preparation workflows, quantification strategies, and applications in cancer research.